HomeOpen Access NewsSH - Apollon Formularies Plc

SH - Apollon Formularies Plc

Subscribe to Updates

The importance of personalised medicine & technology in the future of medical cannabis

Pharma
Dr Stephen Barnhill M.D from Apollon Formularies Plc discusses the potential for technology to upgrade personalised medicine for cannabis treatments.

Medical cannabis & the future of cancer treatments   

Cancer Research
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd